# Rising public interest in stem cell therapy for erectile dysfunction: an analysis of public perception and a review of the literature

## TL;DR

Public interest in stem cell therapy for erectile dysfunction is rising in the U.S., despite limited scientific evidence supporting its effectiveness.

## Contribution

This study uses Google Trends as a novel epidemiological tool to analyze public interest in stem cell therapy for ED.

## Key findings

- Public search interest in stem cell therapy for ED has increased over the past five years.
- Only two clinics provided summaries of clinical trials on stem cell therapy for ED.
- Marketing efforts by commercial entities may be driving public interest in the treatment.

## Abstract

The use of alternative treatment modalities for erectile dysfunction (ED) beyond phosphodiesterase inhibitors continues to grow within the practice of Urology. Utilizing U.S. Google trends as a novel epidemiological tool for geographically associating patient search intent, our study aims to capture trends relating to interest in stem cell therapy (SCT) as a potential treatment for ED.

An online search was conducted to identify centers in the United States offering stem cell therapy (SCT) for erectile dysfunction (ED), using specific keywords such as “ED treatment,” “stem cells for ED,” and “sexual health stem cell.” The geographic distribution of these centers was mapped, and their publicly available information was evaluated based on strict inclusion criteria, including direct claims of SCT efficacy for ED and oversight by a licensed urologist. The public interest in SCT treatment was quantified using Google Trends data from July 2018 to July 2023, utilizing search terms related to SCT and comparing them to terms associated with alternative regenerative therapies like platelet-rich plasma and shockwave treatments, to extract the direction and magnitude of national interest over the preceding 5 years. The PubMed, Cochrane Library, and EMBASE databases were then searched from inception to May 2024 regarding evidence for the use of SCT to treat ED.

Despite insufficient evidence, public search interest demonstrates an upward trajectory of this treatment when compared to alternative regenerative therapies for ED. This increased interest in SCT as a potential treatment option for ED may be linked to the marketing efforts of commercial entities. Throughout the qualitative analysis of advertisement sources, only two websites (Stem Cells Transplant Institute, and Ambrose Cell Therapy) summarized the collective results of a directed clinical trial investigating the utility of SCT in ED patients.

Our study demonstrates the public prevalence of patients seeking SCT as a treatment modality for ED is increasing. In addition, varied sources nationwide promote SCT despite limited scientific evidence and consensus. This disparity calls for additional prospective research on the viability, efficacy, and long-term safety of SCT in the context of ED.

Rising interest in stem cell therapy for erectile dysfunction despite limited evidence

Erectile dysfunction (ED) is a common issue, and people are increasingly searching for new treatments beyond traditional medications. Our study looked at how many people in the U.S. are interested in stem cell therapy (SCT) as a potential treatment for ED, using Google search data to measure this interest. We searched medical databases for studies on SCT for ED and found that there isn’t enough scientific evidence to recommend it as a reliable treatment. However, our analysis of Google search trends over the past five years shows a growing public interest in SCT for ED, compared to other new treatments like shockwave therapy and plasma-rich platelet (PRP) therapy. This increasing interest in SCT might be due to aggressive marketing by clinics offering the treatment. These clinics often highlight the benefits of SCT, such as the simplicity of the procedure and success stories from patients, to make it seem more credible. However, they rarely mention that there is a lack of solid scientific proof supporting these claims. Our findings suggest that while many people are looking into SCT for ED, there is a significant gap between public interest and the scientific evidence available. This highlights the need for more research to determine if SCT is a safe and effective treatment for ED in the long term.